Marshall Wace, LLP Atri Cure, Inc. Transaction History

Marshall Wace, LLP

$78.4 Billion
Q4 2024

A detailed history of Marshall Wace, LLP transactions in Atri Cure, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 619,166 shares of ATRC stock, worth $23.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

619,166

Previous 451,690 37.08%

Holding current value

$23.8 Million

Previous $12.7 Million 49.4%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$27.02 - $38.2 $4.53 Million - $6.4 Million	167,476 Added 37.08%	619,166 $18.9 Million
Q3 2024 Nov 14, 2024	BUY	$20.34 - $29.5 $76,254 - $110,595	3,749 Added 0.84%	451,690 $12.7 Million
Q2 2024 Aug 14, 2024	SELL	$19.86 - $29.09 $10.2 Million - $14.9 Million	-513,418 Reduced 53.41%	447,941 $10.2 Million
Q1 2024 May 15, 2024	BUY	$28.21 - $37.78 $14.8 Million - $19.9 Million	525,946 Added 120.79%	961,359 $29.2 Million
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $2.2 Million - $2.89 Million	66,752 Added 18.11%	435,413 $15.5 Million
Q3 2023 Nov 14, 2023	SELL	$41.12 - $57.73 $669,186 - $939,498	-16,274 Reduced 4.23%	368,661 $16.1 Million
Q2 2023 Aug 14, 2023	SELL	$40.44 - $49.6 $6.75 Million - $8.28 Million	-166,937 Reduced 30.25%	384,935 $19 Million
Q1 2023 May 15, 2023	BUY	$35.87 - $47.22 $19.8 Million - $26.1 Million	551,872 New	551,872 $22.9 Million
Q3 2022 Nov 14, 2022	SELL	$38.25 - $52.62 $277,771 - $382,126	-7,262 Reduced 33.71%	14,282 $559,000
Q2 2022 Aug 15, 2022	BUY	$35.1 - $66.01 $756,194 - $1.42 Million	21,544 New	21,544 $880,000
Q1 2022 May 16, 2022	SELL	$57.43 - $71.39 $41,521 - $51,614	-723 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$63.4 - $87.14 $45,838 - $63,002	723 New	723 $50,000
Q1 2021 May 17, 2021	SELL	$53.79 - $66.98 $11.9 Million - $14.8 Million	-220,737 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$34.56 - $57.55 $7.63 Million - $12.7 Million	220,737 New	220,737 $12.3 Million
Q4 2019 Feb 14, 2020	SELL	$24.06 - $32.51 $1.38 Million - $1.87 Million	-57,401 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$23.81 - $32.52 $3.02 Million - $4.12 Million	-126,840 Reduced 68.84%	57,401 $1.43 Million
Q2 2019 Aug 14, 2019	BUY	$26.85 - $30.74 $4.49 Million - $5.14 Million	167,333 Added 989.67%	184,241 $5.5 Million
Q1 2019 May 14, 2019	BUY	$26.38 - $33.34 $446,033 - $563,712	16,908 New	16,908 $453,000

Others Institutions Holding ATRC

# of Institutions

229

Shares Held

47.1M

Call Options Held

25.8K

Put Options Held

4.5K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.78B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Atri Cure, Inc. Transaction History